Introduction
Benzo[c]phenanthrene (B[c]Ph*) is a polycyclic aromatic hydrocarbon (PAH) which is found prevalently in the environment (1). B[c]Ph, like many other PAH, requires metabolic activation to bay-region diol epoxides to elicit mutagenic and/or carcinogenic effects (2,3)-B[c]Ph-3,4-diol-l,2-epoxides (B[c]PhDE) are among the most carcinogenic diol epoxides tested on mouse skin, newborn mice and in rat mammary tumor assays (2, (4) (5) (6) (7) . B[c]PhDE are highly mutagenic in his-strains TA97, TA98, TA100 and TA104 of Salmonella typhimurium and can induce a mutagenic SOS response in Escherichia coli (3, 8, 9) . Studies in mammalian systems have shown that B[c]PhDE cause mutations in Chinese hamster V79 cells (3, 8, 9, 10) , in the DHFR gene of Chinese hamster ovary cells (11, 12) and in an in vitro B[c]PhDE-treated supF gene replicated in human embryonic adenovirus-transformed kidney cells (13, 14) . Mutations have also been found in the Ha-ras gene of mouse skin and rat mammary tumors induced with B[c]PhDE (15) . This steric hindrance causes the ring system to diverge from planarity. In addition, diol epoxide-1 and diol epoxide-2 diastereomers adopt a pseudo diequatorial conformation of their hydroxyl groups, whereas bay-region diol epoxides, such as the 7,8-diol-9,10^epoxides of benzo[a]pyrene (B[a]P), retain the hydroxyl groups of the diol epoxide-2 diastereomer in a diequatorial configuration and the diol epoxide-1 diastereomer in a diaxial conformation (16) (17) (18) . Fjord-region diol epoxides-1 and -2 of other PAH, such as benzo [c] 
Treatment of cell cultures with B[c]Ph or (±)-B[c]Ph-3,4-dihydwdiol
The human mammary carcinoma cell line, MCF-7, was grown in 175-cm 2 flasks with minimum essential medium supplemented with 10% fetal bovine serum (Intergen, Purchase, NY), 1 mM sodium pyruvate and 0.1 mM nonessential amino acids (Gibco BRL, Gaithersburg, MD). Cultures in which cells covered ~90% of the surface of the flask were refed with fresh medium 24 h prior to treatment. The cells were treated with 10 \iM B[c]Ph or 1 nM (±)-B[c]Ph-3,4-dihydrodiol in 0.1% DMSO (final concentration) for 48 to 96 h. The cells were harvested by trypsinization with 0.05% trypsin-EDTA (0.14 M NaCl, 3 mM KC1, 0.1 M Na 2 HPO 4 , 1.5 mM KH 2 PO 4| 0.5 mM EDTA) and homogenized with 20 strokes in a Dounce homogenizer in 10 mM Tris, 1 raM EDTA containing 1% SDS, pH 8.0. The DNA was isolated by treatments with RNase (50 U/ml) and RNase Tl (1000 U/ml) for 1 h at 37°C, followed by incubation with proteinase K (500 Hg/ml) for 1 h at 37°C. The DNA was extracted with equal volumes of Tris-equilibrated phenol (pH 7.0) followed by extraction with 1/2 volume of Tris-equilibrated phenol and 1/2 volume of chloroform:isoamyl alcohol (24:1). The DNA was extracted again with equal volumes of chloroform: isoamyl alcohol (24:1) and precipitated with 1/10 volume of 5 M NaCl and 2 volumes of cold 100% ethanol. The DNA was dissolved in H 2 O and quantitated on the basis of UV absorbance at 260 nm (1 AU=50 Hg DNA). Slaga et al. 1974 (24) . The DNA from pooled samples was isolated as described above. The labeled, adducted nucleotides were separated from other digestion products by Sep-Pak Qg column chromatography as described previously (25) .
Treatments of mouse skin with B[c]Ph or (±)-B[c]Ph-3,4-dihydrodiol

Analysis of 33 P-postlabeled B[c]Ph-DNA adducts by immobilized boronate chromatography
Isomeric Bfc]Ph-DNA adducts were separated by immobilized boronate chromatography as we have described in the literature (25) with the following modifications. The immobilized boronate column was equilibrated with 50 ml of HEPESKOH buffer (0.05 M HEPESKOH, 0.5 M NaCl, 0.05 M MgCl 2 , pH 9.0). The postlabeled DNA samples were evaporated to 10 Hi and brought up to 1 ml with HEPESKOH buffer. The samples were incubated on the column for 1 h at 4°C. Fifty 1 ml fractions were then eluted with 80% HEPESKOH buffer20% methanol (v/v). The retained adducts were eluted with 10% sorbitol and 0.1 M Tris-HCl (w/v), pH 9.0 and thirty 1 ml fractions were collected. 100 uJ samples were taken of each fraction and the radioactivity was determined by liquid scintillation counting. The fractions with significant radioactivity were pooled and adjusted to pH 5.0 with 0.5 M orthophosphoric acid. The samples were concentrated by Sep-Pak C 18 chromatography and the adducts from both eluates were analyzed by reverse-phase HPLC.
Reverse-phase HPLC analysis of 33 
